Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials-Reference-Cited by-同舟云学术

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials

Published:2012-08 Issue:2 Volume:223 Page:251-261
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Morrone Doralisa,Weintraub William S.,Toth Peter P.,Hanson Mary E.,Lowe Robert S.,Lin Jianxin,Shah Arvind K.,Tershakovec Andrew M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference65 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines;Grundy;J Am Coll Cardiol,2004

3. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk;World Health Organization,2007

4. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation;Brunzell;Diabetes Care,2008

5. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations;Genest;Can J Cardiol,2009

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Economic Burden of Atherosclerotic Cardiovascular Disease in Italy;Clinical Drug Investigation;2024-09-09

2. Ezetimibe use and mortality after myocardial infarction: A nationwide cohort study;American Journal of Preventive Cardiology;2024-09

3. Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: a systematic review and meta-analysis;Annals of Medicine;2024-08-10

4. Sex Differences in Low-Density Lipoprotein Cholesterol Treatment Among Young Israeli Patients Following Premature Acute Coronary Syndrome;Metabolic Syndrome and Related Disorders;2024-08-01

5. Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy;Advances in Therapy;2024-07-04